These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk. Schneider JP. Geriatrics; 2009 Jan; 64(1):18-23. PubMed ID: 19256578 [Abstract] [Full Text] [Related]
12. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?]. Yamaguchi T, Sugimoto T. Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263 [Abstract] [Full Text] [Related]
13. Femoral canal obliteration secondary to prolonged alendronate use: a case report. Lim CT, Setiobudi T, Das De S. J Orthop Surg (Hong Kong); 2012 Apr; 20(1):115-7. PubMed ID: 22535826 [Abstract] [Full Text] [Related]